Ho DM , Yeo CY , Whitman M .

HD29468 NICHD NIH HHS , R01 HD029468 NICHD NIH HHS , 27302C0115 NIEHS NIH HHS

	Fig. 1. p-Smad2 expression in stage 26 embryos. (A) Embryos treated with 100 μM SB-431542 or 0.2% DMSO from stage 13 were dissected into regions 1–4 (head, anterior dorsal trunk, medial dorsal trunk, and posterior dorsal trunk/tailbud, respectively) as indicated on the schematic and Western blotted for p-Smad2. Actin serves as a loading control. (B) Stage 26 embryos treated with SB-431542 or DMSO as in (A) were immunostained with anti-p-Smad2. Tailbuds of stained embryos were photographed without clearing (left column) or with clearing (right column, DMSO only; cleared SB-431542 tailbuds are not shown, as they were almost impossible to photograph due to lack of staining and contrast). tb, tailbud; nt, posterior neural tube.
	Fig. 2. p-Smad2 immunostaining at later tailbud stages. (A) Tailbud-stage embryos were treated with 100 μM SB-431542 or 0.2% DMSO for 22 h prior to harvesting at stage 29 or 36. Embryos were stained with anti-p-Smad2 and cleared. (B) Stage 34 embryos stained for p-Smad2 were cleared to reveal specific structures in the head (top) and tail (bottom). Note that some bilateral structures can be seen twice in cleared heads. br, brain; e, eye; ov, otic vesicle; ba, branchial arches; m, mouth; tb, tailbud; f, fin; nt, posterior neural tube; pw, posterior wall of tailbud; cnh, chordoneural hinge.
	Fig. 3. Expression of Xenopus GDF11. (A) Sequence of Xenopus GDF11 protein. The following conserved regions are present: putative signal sequence (red), TGFβ propeptide domain (blue), TGFβ mature domain (green). Cleavage sites for BMP-1/Tolloid protease (GD, purple) and furin protease (RSRR, orange) are also indicated. (B) Temporal expression profile of xGDF11. RT-PCR was performed on whole embryo samples harvested at indicated stages. xGDF11 RT-PCR was performed on both +RT and −RT samples. Ornithine decarboxylase (ODC) was used as a loading control. (C) In situ hybridization for xGDF11 from stages 13–37. In stages 20–37, anterior is to the left, dorsal to the top. bp, blastopore; tb, tailbud; br, brain; ba, branchial arches; nc, neurenteric canal; pw, posterior wall of tailbud; cnh, chordoneural hinge.
	Fig. 4. GDF11 knockdown results in loss of p-Smad2 at tailbud stages. (A) Confirmation of xGDF11 morpholino oligos. Top panel: embryos were injected with 50 pg xGDF11-3flag mRNA along with 50 ng of tMO or scr-tMO and harvested at stage 10+ (uninjected controls were stage 11) for Western blotting against the flag epitope. Actin was used as a loading control. Bottom panel: embryos injected with 20 ng spMO or cont-MO were harvested at stage 25 for RT-PCR using primers spanning the splice site targeted by spMO. Elongation factor 1a (EF1a) was used as a loading control. (B) Effect of xGDF11 knockdown on p-Smad2 at stage 26/27. Embryos injected with 50 ng xGDF11 tMO or scr-tMO were dissected into regions 1 (head, anterior dorsal trunk, medial dorsal trunk, and posterior dorsal trunk/tailbud, respectively) as indicated in the schematic and Western blotted for p-Smad2. we, whole embryo. Actin was used throughout as a loading control. (C) Effect of xGDF11 knockdown on p-Smad2 and p-Smad1 at stage 34. Embryos injected with 40 ng xGDF11 tMO or cont-MO were dissected into regions 1 as indicated in the schematic and Western blotted for p-Smad2 (top) and p-Smad1 (bottom). (D) xGDF11 knockdown eliminates endogenous p-Smad2 staining in multiple tissues at stage 25. Embryos were injected with 60 ng xGDF11 tMO, 60 ng xGDF11 scr-tMO, 20 ng xGDF11 spMO, or 20 ng xGDF11 scr-spMO and immunostained at stage 25 with anti-p-Smad2. br, brain; e, eye; ba, branchial arches; m, mouth; tb, tailbud.
	Fig. 5. Effect of xGDF11 knockdown on embryonic phenotype. (A) Phenotype of stage 41 embryos injected with 60 ng tMO versus scr-tMO (left), and of stage 40 embryos injected with 20 ng spMO or cont-MO (center), and stage 40 embryos treated with 100 mM SB-431542 or 0.1% DMSO at stage 13. (B) Cell proliferation was measured by phospho-histone H3 staining of tails from stage 40 embryos treated with 60 ng xGDF11 tMO (right) or 60 ng xGDF11 scr-tMO (left). Higher magnification of each tail tip is shown at bottom. Data shown are typical of three separate experiments, a similar reduction in proliferation with xGDF11 knockdown was seen when measured using BrdU incorporation (not shown).
	gdf11.1 ( growth differtiation factor 11, gene 1 ) gene expression in Xenopus laevis embryos, NF stage 20, as assayed by in situ hybridization, lateral view, anterior left, dorsal up.
	gdf11.1 ( growth differtiation factor 11, gene 1 ) gene expression in Xenopus laevis embryos, NF stage 28, as assayed by in situ hybridization, lateral view, anterior left, dorsal up.
	gdf11.1 ( growth differtiation factor 11, gene 1 ) gene expression in Xenopus laevis embryos, NF stage 31, as assayed by in situ hybridization, lateral view, anterior left, dorsal up.
	gdf11.1 ( growth differtiation factor 11, gene 1 ) gene expression in Xenopus laevis embryos, NF stage 37, as assayed by in situ hybridization, lateral view, anterior left, dorsal up.

Anderson, Identification of a novel pool of extracellular pro-myostatin in skeletal muscle. 2008, Pubmed, Xenbase

Anderson, Identification of a novel pool of extracellular pro-myostatin in skeletal muscle. 2008, Pubmed , Xenbase
Beck, Analysis of the developing Xenopus tail bud reveals separate phases of gene expression during determination and outgrowth. 1998, Pubmed , Xenbase
Birsoy, Vg 1 is an essential signaling molecule in Xenopus development. 2006, Pubmed , Xenbase
Chang, Genetic analysis of the mammalian transforming growth factor-beta superfamily. 2002, Pubmed
Dale, Xolloid-related: a novel BMP1/Tolloid-related metalloprotease is expressed during early Xenopus development. 2002, Pubmed , Xenbase
de Sousa Lopes, Distribution of phosphorylated Smad2 identifies target tissues of TGF beta ligands in mouse development. 2003, Pubmed
Dunn, Combinatorial activities of Smad2 and Smad3 regulate mesoderm formation and patterning in the mouse embryo. 2004, Pubmed
Faure, Endogenous patterns of TGFbeta superfamily signaling during early Xenopus development. 2000, Pubmed , Xenbase
Gamer, A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. 1999, Pubmed , Xenbase
Ge, GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells. 2005, Pubmed
Gont, Tail formation as a continuation of gastrulation: the multiple cell populations of the Xenopus tailbud derive from the late blastopore lip. 1993, Pubmed , Xenbase
Goodman, BMP1-related metalloproteinases promote the development of ventral mesoderm in early Xenopus embryos. 1998, Pubmed , Xenbase
Harland, In situ hybridization: an improved whole-mount method for Xenopus embryos. 1991, Pubmed , Xenbase
Ho, TGF-beta signaling is required for multiple processes during Xenopus tail regeneration. 2008, Pubmed , Xenbase
Howell, Xenopus Smad3 is specifically expressed in the chordoneural hinge, notochord and in the endocardium of the developing heart. 2001, Pubmed , Xenbase
Kim, GDF11 controls the timing of progenitor cell competence in developing retina. 2005, Pubmed
Kondaiah, Transforming growth factor-beta5 expression during early development of Xenopus laevis. 2000, Pubmed , Xenbase
Lee, Timing of endogenous activin-like signals and regional specification of the Xenopus embryo. 2001, Pubmed , Xenbase
Liu, The function of growth/differentiation factor 11 (Gdf11) in rostrocaudal patterning of the developing spinal cord. 2006, Pubmed
Makarova, Generation of deletion and point mutations with one primer in a single cloning step. 2000, Pubmed
McPherron, Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. 1997, Pubmed
McPherron, Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. 1999, Pubmed
Nakashima, Expression of growth/differentiation factor 11, a new member of the BMP/TGFbeta superfamily during mouse embryogenesis. 1999, Pubmed
Oh, Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. 2002, Pubmed
Onuma, Multiple nodal-related genes act coordinately in Xenopus embryogenesis. 2002, Pubmed , Xenbase
Piccolo, Cleavage of Chordin by Xolloid metalloprotease suggests a role for proteolytic processing in the regulation of Spemann organizer activity. 1997, Pubmed , Xenbase
Ramis, Xnrs and activin regulate distinct genes during Xenopus development: activin regulates cell division. 2007, Pubmed , Xenbase
Rifkin, Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. 2005, Pubmed
Schohl, Beta-catenin, MAPK and Smad signaling during early Xenopus development. 2002, Pubmed , Xenbase
Wardle, Bone morphogenetic protein 1 regulates dorsal-ventral patterning in early Xenopus embryos by degrading chordin, a BMP4 antagonist. 1999, Pubmed , Xenbase
Watanabe, FAST-1 is a key maternal effector of mesoderm inducers in the early Xenopus embryo. 1999, Pubmed , Xenbase
Whitman, Nodal signaling in early vertebrate embryos: themes and variations. 2001, Pubmed , Xenbase
Wolfman, Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. 2003, Pubmed
Wu, Autoregulation of neurogenesis by GDF11. 2003, Pubmed